AACR Call To Action on Harmful OMB Proposal
Today, AACR submitted comments in response to proposed OMB rules that would severely set back our nation’s medical science enterprise. Submit your comments before 12 a.m. ET tonight.
Act Now
Today, AACR submitted comments in response to proposed OMB rules that would severely set back our nation’s medical science enterprise. Submit your comments before 12 a.m. ET tonight.
Act Now
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe AACR Cancer Disparities Progress Report 2026 is available. The report provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Read the ReportEwing sarcoma is a rare type of cancer with an incidence that is nine times greater in Caucasians than in African Americans. July is Sarcoma Awareness Month.
Learn MoreA grant supported by individual donors to the AACR is helping Madelyn Espinosa-Cotton, PhD, pursue promising new research on a rare form of sarcoma that strikes teens and young adults.
Read AACR StoriesRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSession recordings are available for viewing to registered attendees through October 31. Registration remains open for the on-demand virtual meeting.
The AACR Cancer Disparities Progress Report 2026 provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Learn MoreThe AACR and its more than 61,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 65,000 members worldwide drive progress against cancer.
Donate Now
